Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its third quarter 2025 financial results and recent business activities. Participants may register ...

FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application ...

The 1980s is an era defined by rapid cultural and technological transformation, and it left an undeniable mark on horology ...

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.

Everglades detention facility "Planned in secret, built in secret, and has been operated in secret." Now, a suit challenging ...

Global listed infrastructure reasserted its value as a distinct allocation in 2025, delivering double-digit returns YTD. Read ...

Thank you, Haley, and good morning. Welcome to InterDigital's Third Quarter 2025 Earnings Conference Call. I am Raiford Garrabrant, Head of Investor Relations for InterDigital. With me on today's call ...

"We're getting to the November 21 date that they had been eyeing to fund the government through," said Loren Duggan.

AI-driven, empathetic debt recovery is transforming India’s collections landscape. It is replacing pressure with personalised, respectful communication that boosts repayment, strengthens trust, and ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...

The Ghana cedi has appreciated by 37.4% year-to-date (October 17, 2025), making it the best-performing currency in ...